ALB and liver dysplastic nodule: In the present study, we assessed the effect of combination therapy on the progression of DN by determining albumin excretion rate[18], total protein excretion rate[19], and contents of TGF-β1[20], fibronectin[21], tumor necrosis factor-α (TNF-α)[22], and transferrin[23] and by further studying renal structural changes.